These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1452299)

  • 1. Development of hypertension in animals with reduced total peripheral resistance.
    Huang M; Hester RL; Coleman TG; Smith MJ; Guyton AC
    Hypertension; 1992 Dec; 20(6):828-33. PubMed ID: 1452299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic studies in DOCA-salt hypertensive rats after opening of an arteriovenous fistula.
    Huang M; Hester RL; Guyton AC; Norman RA
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1802-8. PubMed ID: 1621839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac output and the blood pressure increase in deoxycorticosterone acetate-salt hypertension after nicotine infusion.
    Passmore JC; Jimenez AE; Pierce WM
    Clin Exp Hypertens A; 1991; 13(1):83-102. PubMed ID: 2022074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate hemodynamic roles for chloride and sodium in deoxycorticosterone acetate-salt hypertension.
    Passmore JC; Jimenez AE
    Proc Soc Exp Biol Med; 1990 Jul; 194(3):283-8. PubMed ID: 2356192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
    Kohlmann O; Ginoza M; Cezaretti ML; Zanella MT; Ribeiro AB; Tavares A; Ramos OL; Leeman SE; Gavras I; Gavras H
    Hypertension; 1995 Dec; 26(6 Pt 2):1186-9. PubMed ID: 7498993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueduct block markedly reduces mortality and hypertension in post-deoxycorticosterone acetate Dahl salt-resistant rats.
    Lee JY; Tobian L
    Hypertension; 1991 Jun; 17(6 Pt 2):1197-203. PubMed ID: 2045165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats.
    Sato Y; Ito Y; Ando K; Ogata E; Fujita T
    Jpn Heart J; 1990 Sep; 31(5):703-11. PubMed ID: 2148777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic and natriuretic responses to ANF in the presence and absence of renal nerves in DOCA-salt hypertensive rats.
    Patel KP; Zeigler DW
    Clin Exp Hypertens; 1993 Mar; 15(2):257-70. PubMed ID: 8467316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice.
    Obst M; Gross V; Luft FC
    J Hypertens; 2004 Oct; 22(10):1889-94. PubMed ID: 15361759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats.
    Balasubramaniam G; Lee HS; Mah SC
    Eur J Pharmacol; 1995 Mar; 276(1-2):183-90. PubMed ID: 7781688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fast-acting humoral factor mediates pressor hyperresponsiveness in deoxycorticosterone-salt rabbits.
    Johnson JA; McMurray P; Siripaisarnpipat S; Zeigler DW; Koivunen DG; Fowler WL; Payne CG
    Proc Soc Exp Biol Med; 1985 Feb; 178(2):279-87. PubMed ID: 3881774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased release of atrial natriuretic polypeptides in rats with DOCA-salt hypertension.
    Sugimoto T; Ishii M; Hirata Y; Matsuoka H; Sugimoto T; Miyata A; Toshimori T; Masuda H; Kangawa K; Matsuo H
    Life Sci; 1986 Apr; 38(15):1351-8. PubMed ID: 2937987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit?
    Northcott CA; Hayflick JS; Watts SW
    Hypertension; 2004 Apr; 43(4):885-90. PubMed ID: 14993194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.